Weintraub et al. (2010)1414. Weintraub D, Koester J, Potenza MN, Siderowf AD, Stacy M, Voon V et al. Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients. Arch Neurol. 2010 May;67(5):589-95. https://doi.org/10.1001/archneurol.2010.65
https://doi.org/10.1001/archneurol.2010....
|
United States and Canada |
3,09 |
MIDI |
Levodopa 86.8, |
- |
Pramipexole 306.9 (168.2) |
63.8 (8) |
6.5 (3.8-10.6)* |
64.1 |
Inclusion criteria require treatment with a PD medication for at least 1 year. |
DA 66 |
Ropinirole 277.9 (164.9) |
Demented patients were not assessed. |
|
Pergolide 286.6 (169.3) |
|
Weintraub et al. (2013)1212. Weintraub D, Papay K, Siderowf A; Parkinson’s Progression Markers Initiative. Screening for impulse control symptoms in patients with de novo Parkinson disease: a case-control study. Neurology. 2013 Jan;80(2):176-80. https://doi.org/10.1212/WNL.0b013e31827b915c
https://doi.org/10.1212/WNL.0b013e31827b...
|
United States and Canada |
311 |
QUIP |
Untreated |
NA |
NA |
61.5 (9.5) |
- |
71.4 |
Untreated PD patient. |
Vela et al. (2016)1111. Vela L, Martínez Castrillo JC, García Ruiz P, Gasca-Salas C, Macías Macías Y, Pérez Fernández E et al. The high prevalence of impulse control behaviors in patients with early-onset Parkinson’s disease: A cross-sectional multicenter study. J Neurol Sci. 2016 Sep;368:150-4. https://doi.org/10.1016/j.jns.2016.07.003
https://doi.org/10.1016/j.jns.2016.07.00...
|
Spain |
87 |
QUIP |
Levodopa 63 |
510 |
210 (99-300)* |
47.4 (7.9) |
5 (2-11)* |
60.9 |
Assessed only early onset PD (age no greater than 45 years old. |
DA 80.5 |
(210-1000)* |
Antonini et al. (2011)1313. Antonini A, Siri C, Santangelo G, Cilia R, Poletti M, Canesi M et al. Impulsivity and compulsivity in drug-naïve patients with Parkinson’s disease. Mov Disord. 2011 Feb;26(3):464-8. https://doi.org/10.1002/mds.23501
https://doi.org/10.1002/mds.23501...
|
Italy |
103 |
MIDI |
Untreated |
NA |
NA |
60.5 (9.2) |
1.28 (1.28) |
65 |
Untreated. |
Antonini et al. (2017)1515. Antonini A, Barone P, Bonuccelli U, Annoni K, Asgharnejad M, Stanzione P. ICARUS study: prevalence and clinical features of impulse control disorders in Parkinson’s disease. J Neurol Neurosurg Psychiatry. 2017 Apr;88(4):317-24. https://doi.org/10.1136/jnnp-2016-315277
https://doi.org/10.1136/jnnp-2016-315277...
|
Italy |
1,069 |
MIDI and QUIP |
- |
- |
- |
66.3 (9.3) |
5.8 (4.92) |
60.7 |
Demented patients were not assessed. |
Lee et al. (2010)1616. Lee JY, Kim JM, Kim JW, Cho J, Lee WY, Kim HJ et al. Association between the dose of dopaminergic medication and the behavioral disturbances in Parkinson disease. Parkinsonism Relat Disord. 2010 Mar;16(3):202-7. https://doi.org/10.1016/j.parkreldis.2009.12.002
https://doi.org/10.1016/j.parkreldis.200...
|
South Korea |
1,167 |
MIDI |
Levodopa 93.74 |
658.5 (387.1) |
499.3 (347) |
64.9 (9.8) |
6.6 (4.3) |
42.7 |
- |
Sáez-Francàs et al. (2015)1818. Sáez-Francàs N, Martí Andrés G, Ramírez N, Fàbreugues O Álvarez-Sabin J, Casas M et al. [Clinical and psychopathological factors associated with impulse control disorders in Parkinson’s disease]. Neurología. 2016;31(4):231-8. Spanish. https://doi.org/10.1016/j.nrl.2015.05.002
https://doi.org/10.1016/j.nrl.2015.05.00...
|
Spain |
115 |
MIDI |
Levodopa 61.23 |
- |
- |
63.16 (9.06) |
3.09 (1.51 – 6.56)* |
63.5 |
Demented patients were not assessed. |
DA 69.57 |
Garcia-Ruiz et al. (2014)1919. Garcia-Ruiz PJ, Martinez Castrillo JC, Alonso-Canovas A, Herranz Barcenas A, Vela L, Sanchez Alonso P et al. Impulse control disorder in patients with Parkinson’s disease under dopamine agonist therapy: a multicentre study. J Neurol Neurosurg Psychiatry. 2014 Aug;85(8):840-4. https://doi.org/10.1136/jnnp-2013-306787
https://doi.org/10.1136/jnnp-2013-306787...
|
Spain |
233 |
QUIP |
Levodopa 75.1 |
723.8 (422.2) |
202 (93.3) |
66 (9.7) |
- |
62.2 |
All patients were taking DA (exposure time 5.9 +-4.1 years). |
DA 100 |
Demented patients were not assessed. |
Perez-Lloret et al. (2012)2020. Perez-Lloret S, Rey MV, Fabre N, Ory F, Spampinato U, Brefel-Courbon C et al. Prevalence and pharmacological factors associated with impulse-control disorder symptoms in patients with Parkinson disease. Clin Neuropharmacol. 2012 Nov-Dec;35(6):261-5. https://doi.org/10.1097/WNF.0b013e31826e6e6d
https://doi.org/10.1097/WNF.0b013e31826e...
|
France |
203 |
QUIP |
Levodopa 87 |
1188 (88) |
- |
67 (1) |
9 (1) |
62 |
Demented patients were not assessed. |
DA 80 |
De Chazeron et al. (2011) 2121. de Chazeron I, Llorca PM, Chéreau-Boudet I, Blanc O, Perriot J, Ouchchane L et al. Hypersexuality and pathological gambling in Parkinson’s disease: A cross-sectional case-control study. Mov Disord. 2011 Sep;26(11):2127-30. https://doi.org/10.1002/mds.23845
https://doi.org/10.1002/mds.23845...
|
France |
115 |
Clinical criteria |
Levodopa 87.83 |
631 (436) |
130 (168) |
67 (6) |
7 (4) |
- |
Only hypersexuality and gambling disorder assessed. |
(questionnaires on addiction) |
DA 56.52 |
Poletti et al. (2013)2222. Poletti M, Logi C, Lucetti C, Del Dotto P, Baldacci F, Vergallo A et al. A single-center, cross-sectional prevalence study of impulse control disorders in Parkinson disease: association with dopaminergic drugs. J Clin Psychopharmacol. 2013 Oct;33(5):691-4. https://doi.org/10.1097/JCP.0b013e3182979830
https://doi.org/10.1097/JCP.0b013e318297...
|
Italy |
805 |
QUIP |
Levodopa 85.6 |
- |
- |
72.5 (9.5) |
9.9 (7.2) |
59.8 |
Demented patients were assessed as well. |
DA 49.8 |
Drug-naïve PD patients were not assessed. |
Joutsa et al. (2012)2323. Joutsa J, Martikainen K, Vahlberg T, Voon V, Kaasinen V. Impulse control disorders and depression in Finnish patients with Parkinson’s disease. Parkinsonism Relat Disord. 2012 Feb;18(2):155-60. https://doi.org/10.1016/j.parkreldis.2011.09.007
https://doi.org/10.1016/j.parkreldis.201...
|
Finland |
575 |
QUIP |
Levodopa 78.7 |
561 (26-3230)* |
160 (105-210)* |
64 (43-90)* |
6 (<1 -29)* |
60 |
Demented patients were not assessed. |
DA 74.9 |
Callesen et al. (2013)2424. Callesen MB, Weintraub D, Damholdt MF, Møller A. Impulsive and compulsive behaviors among Danish patients with Parkinson’s disease: prevalence, depression, and personality. Parkinsonism Relat Disord. 2014 Jan;20(1):22-6. https://doi.org/10.1016/j.parkreldis.2013.09.006
https://doi.org/10.1016/j.parkreldis.201...
|
Denmark |
490 |
QUIP |
- |
555.4 (392.2) |
114.8 (141.9) |
71 (9.6) |
8.3 (6.3) |
61.8 |
Demented patients were not assessed. |
Fan et al. (2009)2525. Fan W, Ding H, Ma J, Chan P. Impulse control disorders in Parkinson’s disease in a Chinese population. Neurosci Lett. 2009 Nov;465(1):6-9. https://doi.org/10.1016/j.neulet.2009.06.074
https://doi.org/10.1016/j.neulet.2009.06...
|
China |
312 |
SOGS, Lejoyeux’s Compulsive Shopping Questionnaire, DSM-IV criteria |
Levodopa 81.41 |
- |
- |
65.77 (34-88)* |
5.67 (1-19)* |
61.9 |
Demented patients were not assessed. |
Zhang et al. (2017)2626. Zhang Y, He AQ, Li L, Chen W, Liu ZG. Clinical characteristics of impulse control and related disorders in Chinese Parkinson’s disease patients. BMC Neurol. 2017 May;17(1):98. https://doi.org/10.1186/s12883-017-0874-6
https://doi.org/10.1186/s12883-017-0874-...
|
China |
142 |
QUIP |
Levodopa |
389.4 (373.72) |
41.9 (52.13) |
68.39 (8.14) |
6 (5.56) |
51.4 |
Demented patients were not assessed. |
68.3 |
DA 49.3 |
Auyeung et al. (2011)2727. Auyeung M, Tsoi TH, Tang WK, Cheung CM, Lee CN, Li R et al. Impulse control disorders in Chinese Parkinson’s disease patients: the effect of ergot derived dopamine agonist. Parkinsonism Relat Disord. 2011 Sep;17(8):635-7. https://doi.org/10.1016/j.parkreldis.2011.06.001
https://doi.org/10.1016/j.parkreldis.201...
|
China (Hong Kong) |
213 |
QUIP |
Levodopa 94.8 |
674.9 (387.5) |
98.7 (113.7) |
67.5 (9.9) |
9.3 (5) |
59.6 |
Demented patients were not assessed. |
DA 53.06 |
Chiang et al. (2011)2828. Chiang HL, Huang YS, Chen ST, Wu YR. Are there ethnic differences in impulsive/compulsive behaviors in Parkinson’s disease? Eur J Neurol. 2012 Mar;19(3):494-500. https://doi.org/10.1111/j.1468-1331.2011.03571.x
https://doi.org/10.1111/j.1468-1331.2011...
|
Taiwan |
268 |
DSM-IV and clinical criteria |
- |
531.48 (20.32) |
61.97 (6.12) |
70.2 (0.6) |
8.6 (0.3) |
62.31 |
Demented patients were not assessed. |
Valença et al. (2013)2929. Valença GT, Glass PG, Negreiros NN, et al. Past smoking and current dopamine agonist use show an independent and dose-dependent association with impulse control disorders in Parkinson’s disease. Parkinsionism Relat Disord. 2013;19(7):698-700. Https://doi.org/10.1016/j.parkreldis.2013.03.004
Https://doi.org/10.1016/j.parkreldis.201...
|
Brazil |
152 |
QUIP |
DA 26.32 |
- |
- |
67.3 (10.4) |
7.2 (5.3) |
56.6 |
Demented patients were not assessed. |
Ramírez-Gómez et al. (2017)3030. Ramírez Gómez CC, Serrano Dueñas M, Bernal O, Araoz N, Sáenz Farret M, Aldinio V et al. A Multicenter comparative study of impulse control disorder in Latin American patients with Parkinson Disease. Clin Neuropharmacol. 2017 Mar/Apr;40(2):51-55. https://doi.org/10.1097/WNF.0000000000000202
https://doi.org/10.1097/WNF.000000000000...
|
Argentina, Colombia, Ecuador |
255 |
QUIP |
DA 95.27 |
- |
- |
68 (15) |
- |
- |
Demented patients were not assessed. |
Rodríguez-Violante et al. (2014)3232. Rodríguez-Violante M, González-Latapi P, Cervantes-Arriaga A, Camacho-Ordoñez A, Weintraub D. Impulse control and related disorders in Mexican Parkinson’s disease patients. Parkinsionism Relat Disord. 2014;20(8):907-10. https://doi.org/10.1016/j.parkreldis.2014.05.014
https://doi.org/10.1016/j.parkreldis.201...
|
Mexico |
300 |
MIDI and QUIP |
Levodopa 74 |
580.9 (425.9) |
174.5 (110.7) |
61.7 (13) |
|
54.3 |
Only poor patients (average household income < 500 USD – monthly) |
DA 57 |